Management of gout in primary care of Hong Kong in accordance with international guidelines: any gaps to bridge?
60.3% of gout patients were treated with urate-lowering agents in public primary care settings in Hong Kong, while only 29.9% of gout patients and none of tophaceous gout patients were adequately treated. Male patients, active smokers or comorbid with CKD stage 3a, 3b and 4 were less likely to achieve target urate control.
Authors
- Catherine Xiaorui Chen
- Khek Yu Ho (ORCID: https://orcid.org/0000-0002-2932-1962)
- Yimchu Li
- Lapkin Chiang
- Sun-Young Ko (ORCID: https://orcid.org/0000-0002-1108-8381)
- K. Chan (ORCID: https://orcid.org/0009-0003-1295-2076)
Institutions
- Hospital Authority (HK)
- Queen Elizabeth Hospital (CN)
Publication Details
- Journal
- BMC Primary Care
- Published
- 2025-02-12
- DOI
- https://doi.org/10.1186/s12875-024-02664-2
- Citations
- 2
- Primary Topic
- Gout, Hyperuricemia, Uric Acid
- Type
- article
- Field-Weighted Citation Impact
- 2.86
Funders
- Chinese University of Hong Kong
- Global Obesity Prevention Center, Johns Hopkins University